Widely Recognized Certifications Further Validate BioServe’s Operational and Organizational Excellence
Laurel, MD, March 27, 2007 – BioServe Biotechnologies, the leader for fast, economical processing and analyses of genomic content from biological samples, today announced it has received two milestone certifications — ISO (International Organization for Standardization) 9001 and CLIA (Clinical Laboratory Improvement Act).
ISO is a worldwide federation of national standards adopted by 154 countries and has become an international reference for quality management requirements in business-to-business dealings. BioServe chose to have its site in India certified by ISO, a process that includes comprehensive and rigorous auditing, to actively illustrate its commitment to provide only the best quality products and service for its customers.
CLIA is a regulatory program that sets standards for operating a clinical laboratory in the USA, and it mandates that any laboratory conducting testing on human specimens must be certified to operate in accordance with the federal government’s Clinical Laboratory Improvement Act.
“These certifications further validate BioServe’s operational and organizational excellence,” said Rama Modali, President of BioServe. “For the past 15 years BioServe has delivered superior services for extracting and analyzing genomic content. BioServe’s customers, whether a bio-pharmaceutical company or a public research institution, have come to expect the highest quality work with reduced project cycle times, along with the ability to overcome challenging business and scientific hurdles. With the ISO and CLIA certifications, our customers can be confident of our continued commitment to providing the highest quality services, products and technology.”